Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Swiss drugmaker Roche said on Friday it would buy U.S. cancer drugmaker Ignyta for $1.7 billion.
Friday, December 22, 2017
Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Swiss drugmaker Roche said on Friday it would buy U.S. cancer drugmaker Ignyta for $1.7 billion.
Related Posts:
California Gov. Gavin Newsom recall effort leader on Hollywood survival push: He’s ‘not beloved’- Gas prices dodge Hurricane Ida catastrophe
- Markets open the week with new highs
- Fmr. Afghanistan mayor details Taliban escape: ‘Never expecting them to leave me alive’
- Ideanomics buying electric truck startup Via Motors for $630 million
0 comments:
Post a Comment